Whole-body MRI scans 4.6 years apart compared 58 adults with diabetes who started a GLP-1 drug with 130 matched adults who did not. Skeletal muscle volume fell 2.75 percentage points further in those who started the drug. Weight loss was 2.54 percentage points greater, while the differences in internal and subcutaneous fat were not statistically significant.
Why it is interesting: Muscle measured directly by imaging, in routine care rather than in a trial.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.